At a glance
ClinicalIndex Comparison RecordN/ACompleted· 703 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee DR) for Screening of Diabetic Retinopathy in Patients With Diabetes Mellitus
In Brief
An observational study for Diabetic Retinopathy. Completed, enrolled 703 participants across 1 site.
Detailed Summary
This study is to evaluate the clinical performance of VeriSee DR for DR screening from color fundus photography images in patients with diabetes mellitus. The sensitivity and specificity of VeriSee DR's automated image analysis for screening the diabetes retinopathy will be determined.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Retinopathy
CountriesTaiwan
CollaboratorsNational Taiwan University Hospital
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedNov 2019
Enrollment StartDec 2019
Primary CompletionJan 2020
Study CompletionMay 2020
TodayJul 2026
First PostedNov 13, 2019
Enrollment StartDec 16, 2019
Primary CompletionJan 31, 2020
Study CompletionMay 11, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.6 years ago